Chemoprophylaxis Plus Early Ambulation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 581 participants.

Also called NCT03862755

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 581 participants (enrolled count) (from the registry)
Sponsor
Shen Lei (from the registry)
Registry
  • NCT NCT03862755
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03862755. Allocation not applicable; no masking; primary purpose prevention. Start 2017-08-08 (actual); primary completion 2017-09-12 (actual). Results posted on 2021-11-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Chemoprophylaxis Plus Early Ambulation
Condition
Thoracic Surgery
Intervention (Drug)
Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
Lead sponsor
Shen Lei (class: other)

Record details

Record id
cardio:ct-nct03862755
Content hash
1ac225e42c62dc53c7bb46657798dc88cadbdaba4e69344b16045b31229e7c01